evaluation long-term glycemic control non-insulin-dependent diabetes mellitus relevance glycated hemoglobin Thirty-six patients open study long-term efficacy gliclazide treatment type II mellitus Results patients months months months follow-up overall reduction fasting postprandial blood sugar Total glycated hemoglobin values reference range cases Body stable period observation months incidence subsequent failure oral treatment annum results long-term treatment type II gliclazide leads satisfactory results side effects 